By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Becton Dickinson AG 

Postfach Immengasse 7

Basel    CH-4002  Switzerland
Phone: 41-0-61-385-4422 Fax: 41-0-61-385-4400




Intergen Company 

Company News
U.K. Healthcare Regulators Warn of "Buckling" Becton Dickinson AG Catheters 10/24/2013 9:15:07 AM
Becton Dickinson AG Says Former Engineer Planned to Flee to India With Trade Secrets 6/10/2013 8:52:39 AM
Becton Dickinson AG Gets FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS™ Passive Needle Guard 4/11/2013 6:52:41 AM
Becton Dickinson AG Release: Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis 2/28/2013 10:42:53 AM
Judge: Becton Dickinson AG Infringed Hologic, Inc. (HOLX)'s Patents 10/4/2012 9:14:46 AM
Becton Dickinson AG and Diagenode, Inc. Collaborate to Expand Infectious Disease Menu on the BD MAX(TM) System 5/9/2011 7:52:34 AM
Exiqon A/S Licenses Locked Nucleic Acids for Infectious Disease Diagnostics to Becton Dickinson AG 6/21/2010 9:29:47 AM
Accelr8 Technology Corporation (OTC-BB: ACLY) And Becton Dickinson AG Conclude Technical Development Project 9/25/2009 11:24:54 AM
Option Period Extended on Becton Dickinson AG - Tyrian Diagnostics Agreement 5/13/2009 9:55:45 AM
Successful Completion Of NorDiag ASAs Clinical Trial Tailored To The Becton Dickinson AG Probetec(TM) Et System 11/12/2008 3:39:37 PM